甲状腺乳头状癌原发灶外科治疗探讨
|
摘要
近年来甲状腺癌发病率在世界范围内呈上升趋势,其中甲状腺乳头状癌是甲状腺癌最常见的病理学类型,经过多年探索,现已形成手术切除为主,放射性碘治疗和甲状腺激素内分泌治疗为辅。由于甲状腺乳头状癌病理学特点、个体差异、对疾病不同的认识,国内、国外学者对甲状腺乳头状癌的治疗未形成统一意见,以手术治疗中的原发灶切除范围最明显。
In recent years, the incidence of thyroid carcinoma in the world is rising, and the papillary thyroid carcinoma is the most common type. After many years of practice, surgical treatment has been formed primarily, radioactive iodine treatment and thyroid hormone endocrine system as adjuvant therapy. Due to the biological characteristics of thyroid papillary carcinoma, individul differences and the healer of disease different understanding, scholars at ho-me and abroad for the treatment is still not form a unified regulation. The rang of surgical treatment of surgery is the most obvious.
In recent years, the incidence of thyroid carcinoma in the world is rising, and the papillary thyroid carcinoma is the most common type. After many years of practice, surgical treatment has been formed primarily, radioactive iodine treatment and thyroid hormone endocrine system as adjuvant therapy. Due to the biological characteristics of thyroid papillary carcinoma, individul differences and the healer of disease different understanding, scholars at ho-me and abroad for the treatment is still not form a unified regulation. The rang of surgical treatment of surgery is the most obvious.
引文
[1]Mc Neil C.Annual cancer statistics report raises key questions[J].Journal of the National Cancer Institute,2006,98(22):1598-1599.
[2]田兴松,刘奇.实用甲状腺外科学[M].北京:人民军医出版社,2009:75-79.
[3]蒋国梁.临床肿瘤学[M].上海:上海科学技术文献出版社,2004:445.
[4]张伦,李树玲.1173例甲状腺乳头状癌外科远期疗效观察[J].中国肿瘤临床,2003,34(22):805-808.
[5]武鸿彪,付强,朱理玮.甲状腺乳头状癌的手术治疗方式比较[J].中国中西医结合外科杂志,2011,17(2):154-156.
[6]李树玲.我国甲状腺癌外科现状与展望[J].临床外科杂志,2006,14(3):129-130.
[7]徐德龙,刘宁青,肖文华.甲状腺结节的定性诊断和治疗[J].中华普通外科杂志,1997,12(6):375.
[8]曾令民.中国人分化良好之甲状腺癌的手术治疗与预后因子:二十年处理经验[J].中华医学杂志,1996,58(2):121-131.
[9]高明.甲状腺癌诊治进展[J].肿瘤学杂志,2003,9(1):40-44.
[10]崔华,速金华.甲状腺乳头状癌95例外科治疗分析[J].中国民族民间医药.2012,21(8):95-96.
[11]刘经祖,金锐,陶英杰.甲状腺乳头状及滤泡状癌的手术范围[J].临床外科杂志,2000,8(4):241-242.
[12]Tollefsen HR,Shah JP,Huvos AG.Papillary carcinoma of the thyroid recurrence in the thyroid gland after initial surgical treatment[J].Am J Surg,1972,124(4):468.
[13]Haigh PI,Urbach DR,Rostein LE.Extent of thyroidectomy is not a major determinant of survival in low or highrisk papillary thyroid cancer[J].Annals of Surgical Oncology,2005,12(1):81-89.
[14]Davies L,Welch HG.Thyroid cancer survival in the United States:Observational data from 1973 to 2005[J].Arch Otolaryngol Head Neck Surg,2010,136(5):440-444.
[15]腾卫平,刘永峰,高明,等.甲状腺结节和分化型甲状腺癌诊治指南[S].2012:17.
[16]伍植文,罗胜,赖立扬,等.甲状腺全切除术联合同位素治疗乳头状甲状腺癌38例的疗效[J].实用临床医学,2012,13(11):37-39.
[17]周根成,张卫文,姚叙.全甲状腺切除术治疗甲状腺癌87例[J].医药论坛杂志,2012,33(5):73-74.
[18]陆永广.甲状腺全切术治疗乳头状腺癌[J].临床研究,2012,20(11):69.
[19]何俭东.甲状腺全切术治疗分化型甲状腺癌[J].中外医学研究,2013,11(28):179.
[20]Tufano Ralph P,Kandil E mad.Considerations for personalized surgery in patients with papillary thyroid cancer[J].Thyroid,2010,20(7):771-776.
[21]Mazzaferri EL,Jhiang SM.Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J].Am J Med,1994,97(5):418-428.
[22]Glockzin GH,ornung M,Kienle K,et al.Completion thyroidectomy effect of timing on clinical complcations and onclologic outcome in patients with differentiated thyroid cancer[J].World J Surg,2012,36(5):1168-1173.
[23]徐先发,唐玲,李洪跃,等.甲状腺全切除术的安全性及有效性探讨[J].临床外科杂志,2010,18(5):329-331.
[24]张滨,李福荣,冯江,等.甲状腺全切治疗分化型甲状腺癌的临床意义和并发症分析[J].现代肿瘤医学,2013,21(9):1967-1969.
[25]边勇.甲状腺全切术的安全性分析[J].中国医药指南,2013,11(15):461.
[26]王会元,王晓辉,李非,等.甲状腺全切除术的适应证及安全性分析[J].中国普外基础与临床杂志,2013,20(4):427-431.
[27]Schmitz-Winnenthal FH,Schimmack S,Lawrence B,et al.Quality of life is not influenced by the extent of surgery in patients with benign goiter[J].Langenbecks Arch Surg,2011,396(8):1157-1163.
[28]张少强,姚小宝,白艳霞,等.甲状腺全切术的安全性分析[J].临床耳鼻咽喉头颈外科杂志,2011,25(9):817-822.
[29]Harness JK,Van Heerden JA,Lennquist S.Future of thyroid surgery and training surgeons to meet the expectations of 2000 and beyond[J].World Journal Surgery,2000,24(8):976.
[30]Jonklaas J,Sarlis NJ,Litofsky D,et al.Outcomes of patients with differentiated thyroid carcinoma following initial therapy[J].Thyroid,2006,16(12):1229-1242.
[31]Bilimoria KY,Bentrem DJ,Ko CY,et al.Extent of surgery affects survival for papillary thyroid cancer[J].Ann Surg,2007,246(3):375-381.
[32]张德恒.分化型甲状腺癌的临床病理特征及手术范围[J].临床外科杂志,2006,14(3):134.
[33]White M L,Gauger PG,Doherty GM.Central lymph node dissection in differentiated thyroid cancer[J].World J Surg,2007,31(5):897.
[34]纪宗正.分化型甲状腺癌的诊断和治疗[J].临床外科杂志,2006,14(3):133.
[35]王军.家族性乳头状癌的外科治疗[J].河南医药信息,2002,10(6):11-12.
[36]李树玲.头颈肿瘤学[M].天津:天津科学技术出版社,1993:717-756.
[37]杨明.甲状腺乳头状癌术式探讨[J].实用全科医学,2007,5(7):575-576.
[2]田兴松,刘奇.实用甲状腺外科学[M].北京:人民军医出版社,2009:75-79.
[3]蒋国梁.临床肿瘤学[M].上海:上海科学技术文献出版社,2004:445.
[4]张伦,李树玲.1173例甲状腺乳头状癌外科远期疗效观察[J].中国肿瘤临床,2003,34(22):805-808.
[5]武鸿彪,付强,朱理玮.甲状腺乳头状癌的手术治疗方式比较[J].中国中西医结合外科杂志,2011,17(2):154-156.
[6]李树玲.我国甲状腺癌外科现状与展望[J].临床外科杂志,2006,14(3):129-130.
[7]徐德龙,刘宁青,肖文华.甲状腺结节的定性诊断和治疗[J].中华普通外科杂志,1997,12(6):375.
[8]曾令民.中国人分化良好之甲状腺癌的手术治疗与预后因子:二十年处理经验[J].中华医学杂志,1996,58(2):121-131.
[9]高明.甲状腺癌诊治进展[J].肿瘤学杂志,2003,9(1):40-44.
[10]崔华,速金华.甲状腺乳头状癌95例外科治疗分析[J].中国民族民间医药.2012,21(8):95-96.
[11]刘经祖,金锐,陶英杰.甲状腺乳头状及滤泡状癌的手术范围[J].临床外科杂志,2000,8(4):241-242.
[12]Tollefsen HR,Shah JP,Huvos AG.Papillary carcinoma of the thyroid recurrence in the thyroid gland after initial surgical treatment[J].Am J Surg,1972,124(4):468.
[13]Haigh PI,Urbach DR,Rostein LE.Extent of thyroidectomy is not a major determinant of survival in low or highrisk papillary thyroid cancer[J].Annals of Surgical Oncology,2005,12(1):81-89.
[14]Davies L,Welch HG.Thyroid cancer survival in the United States:Observational data from 1973 to 2005[J].Arch Otolaryngol Head Neck Surg,2010,136(5):440-444.
[15]腾卫平,刘永峰,高明,等.甲状腺结节和分化型甲状腺癌诊治指南[S].2012:17.
[16]伍植文,罗胜,赖立扬,等.甲状腺全切除术联合同位素治疗乳头状甲状腺癌38例的疗效[J].实用临床医学,2012,13(11):37-39.
[17]周根成,张卫文,姚叙.全甲状腺切除术治疗甲状腺癌87例[J].医药论坛杂志,2012,33(5):73-74.
[18]陆永广.甲状腺全切术治疗乳头状腺癌[J].临床研究,2012,20(11):69.
[19]何俭东.甲状腺全切术治疗分化型甲状腺癌[J].中外医学研究,2013,11(28):179.
[20]Tufano Ralph P,Kandil E mad.Considerations for personalized surgery in patients with papillary thyroid cancer[J].Thyroid,2010,20(7):771-776.
[21]Mazzaferri EL,Jhiang SM.Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J].Am J Med,1994,97(5):418-428.
[22]Glockzin GH,ornung M,Kienle K,et al.Completion thyroidectomy effect of timing on clinical complcations and onclologic outcome in patients with differentiated thyroid cancer[J].World J Surg,2012,36(5):1168-1173.
[23]徐先发,唐玲,李洪跃,等.甲状腺全切除术的安全性及有效性探讨[J].临床外科杂志,2010,18(5):329-331.
[24]张滨,李福荣,冯江,等.甲状腺全切治疗分化型甲状腺癌的临床意义和并发症分析[J].现代肿瘤医学,2013,21(9):1967-1969.
[25]边勇.甲状腺全切术的安全性分析[J].中国医药指南,2013,11(15):461.
[26]王会元,王晓辉,李非,等.甲状腺全切除术的适应证及安全性分析[J].中国普外基础与临床杂志,2013,20(4):427-431.
[27]Schmitz-Winnenthal FH,Schimmack S,Lawrence B,et al.Quality of life is not influenced by the extent of surgery in patients with benign goiter[J].Langenbecks Arch Surg,2011,396(8):1157-1163.
[28]张少强,姚小宝,白艳霞,等.甲状腺全切术的安全性分析[J].临床耳鼻咽喉头颈外科杂志,2011,25(9):817-822.
[29]Harness JK,Van Heerden JA,Lennquist S.Future of thyroid surgery and training surgeons to meet the expectations of 2000 and beyond[J].World Journal Surgery,2000,24(8):976.
[30]Jonklaas J,Sarlis NJ,Litofsky D,et al.Outcomes of patients with differentiated thyroid carcinoma following initial therapy[J].Thyroid,2006,16(12):1229-1242.
[31]Bilimoria KY,Bentrem DJ,Ko CY,et al.Extent of surgery affects survival for papillary thyroid cancer[J].Ann Surg,2007,246(3):375-381.
[32]张德恒.分化型甲状腺癌的临床病理特征及手术范围[J].临床外科杂志,2006,14(3):134.
[33]White M L,Gauger PG,Doherty GM.Central lymph node dissection in differentiated thyroid cancer[J].World J Surg,2007,31(5):897.
[34]纪宗正.分化型甲状腺癌的诊断和治疗[J].临床外科杂志,2006,14(3):133.
[35]王军.家族性乳头状癌的外科治疗[J].河南医药信息,2002,10(6):11-12.
[36]李树玲.头颈肿瘤学[M].天津:天津科学技术出版社,1993:717-756.
[37]杨明.甲状腺乳头状癌术式探讨[J].实用全科医学,2007,5(7):575-576.